دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Mortality in spontaneous coronary artery dissection: A systematic review and meta-analysis
Cobi Adams MD,Maggie He MD,Ian Hughes PHD,Kuljit Singh MBBS, FRACP, PHD
doi : 10.1002/ccd.29488
Volume 98, Issue 7 p. 1211-1220
The aim of this systematic review and meta-analysis was to provide a comprehensive estimate for spontaneous coronary artery dissection (SCAD) related mortality, and explore factors associated with an increased risk of death.
Tobacco and Venus may reduce man to ashes, even when Bacchus is on vacation
Tiziana Claudia Aranzulla MD, MSc,Giuseppe Musumeci MD
doi : 10.1002/ccd.29997
Volume 98, Issue 7 p. 1221-1222
Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention
Mary C. Shields MD,Michelle Ouellette MD,Nicholas Kiefer MD,Luke Kohan MD,Angela M. Taylor MD,Gorav Ailawadi MD,Michael Ragosta MD
doi : 10.1002/ccd.29508
Volume 98, Issue 7 p. 1223-1229
In this study we evaluated the clinical characteristics and outcomes of surgically ineligible patients with coronary artery disease (CAD) who underwent multivessel percutaneous coronary intervention (PCI).
Surgical turndowns are not no option patients
George W. Vetrovec MD
doi : 10.1002/ccd.29995
Volume 98, Issue 7 p. 1230-1231
Same day discharge after chronic total occlusion interventions: A single center experience
Michael Koutouzis MD,Catherine Liontou MD,Iosif Xenogiannis MD,Peter Tajti MD,Ioannis Tsiafoutis MD,Efstathios Lazaris MD,Nikolaos Oikonomidis MD,Eleftherios Kontopodis MD,Bavana Rangan AD,Emmanouil Brilakis MD
doi : 10.1002/ccd.29320
Volume 98, Issue 7 p. 1232-1239
To assess the feasibility and safety of same day discharge (SDD) after chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Everything is outpatient these days: The new economics of sophisticated cardiovascular care
Nachiket J. Patel MD,Richard R. Heuser MD
doi : 10.1002/ccd.29991
Volume 98, Issue 7 p. 1240-1240
Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry
Soledad Ojeda MD, PhD,Lorenzo Azzalini MD, PhD, MSc,Javier Suárez de Lezo MD, PhD,Gurpreet S. Johal MD,Rafael González MD,Nitin Barman MD,Francisco Hidalgo MD, PhD,Neus Bellera MD, PhD,George Dangas MD, PhD,Alfonso Jurado-Román MD, PhD,Annapoorna Kini MD,Miguel Romero MD, PhD,Raúl Moreno MD, PhD,Bruno Garcia del Blanco MD, PhD,Roxana Mehran MD,Samin K. Sharma MD,Manuel Pan MD, PhD
doi : 10.1002/ccd.29392
Volume 98, Issue 7 p. 1241-1249
To assess the efficacy and safety of excimer laser coronary atherectomy (ELCA), as well as, the long-term outcomes and the factors associated with ELCA failure in uncrossable lesions.
Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations
On Topaz MD, FACP, FSCAI
doi : 10.1002/ccd.29993
Volume 98, Issue 7 p. 1250-1251
Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic
Mohamed O. Mohamed MRCP,Nick Curzen PhD FRCP,Mark de Belder MD FRCP,Andrew T. Goodwin PhD FRCS(CTh),James C Spratt MD,Lognathen Balacumaraswami MD,John Deanfield FRCP,Glen P. Martin PhD,Muhammad Rashid PhD,Ahmad Shoaib MD,Chris P Gale PhD FRCP,Tim Kinnaird MD,Mamas A. Mamas DPhil
doi : 10.1002/ccd.29663
Volume 98, Issue 7 p. 1252-1261
There are limited data on the impact of the COVID-19 pandemic on left main (LM) coronary revascularisation activity, choice of revascularisation strategy, and post-procedural outcomes.
Left main coronary revascularization strategies in the COVID-19 era
Ran Kornowski MD, FESC, FACC
doi : 10.1002/ccd.29988
Volume 98, Issue 7 p. 1262-1263
Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials
Mir B. Basir DO,Duane S. Pinto MD,Boback Ziaeian MD, PhD,Akshay Khandelwal MD,Jennifer Cowger MD,William Suh MD,Andrew Althouse PhD
doi : 10.1002/ccd.29593
Volume 98, Issue 7 p. 1264-1274
Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is associated with significant morbidity and mortality.
Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score
Qussay Marashly MD,Iosif Taleb MD,Christos P. Kyriakopoulos MD,Elizabeth Dranow PhD,Tara L. Jones MD, PharmD,Anwar Tandar MD,Sean D. Overton MD,Joseph E. Tonna MD, MS,Kathleen Stoddard RN,Omar Wever-Pinzon MD,Line Kemeyou MD,Antigone G. Koliopoulou MD,Kevin S. Shah MD,Kimiya Nourian BS, MS,Tyler J. Richins BS,Tyson S. Burnham BS,Frederick G. Welt MD,Stephen H. McKellar MD, MSc,Jose Nativi-Nicolau MD,Stavros G. Drakos MD, PhD
doi : 10.1002/ccd.29581
Volume 98, Issue 7 p. 1275-1284
To identify predictors of 30-day all-cause mortality for patients with cardiogenic shock secondary to acute coronary syndrome (ACS-CS) who require short-term mechanical circulatory support (ST-MCS).
Risk prediction in cardiogenic shock
Matthew I. Tomey MD,George D. Dangas MD, PhD
doi : 10.1002/ccd.29996
Volume 98, Issue 7 p. 1285-1286
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score
Ply Chichareon MD,David van Klaveren PhD,Rodrigo Modolo MD,Norihiro Kogame MD,Kuniaki Takahashi MD,Chun-Chin Chang MD,Mariusz Tomaniak MD,Jinqing Yuan MD,Lihua Xie MSc,Ying Song MD,Shubin Qiao MD,Yuejin Yang MD,Changdong Guan MSc,Aleksander Zurakowski MD, PhD,Robert-Jan van Geuns MD, PhD,Manel Sabate MD,Paul J. Ong MD,Joanna J. Wykrzykowska MD, PhD,Jan J. Piek MD, PhD,Scot Garg MBChB, PhD,Christian Hamm MD,Gabriel Steg MD,Pascal Vranckx MD, PhD,Marco Valgimigli MD, PhD,Stephan Windecker MD,Peter Juni MD,Yoshinobu Onuma MD, PhD,Ewout Steyerberg PhD,Bo Xu MBBS,Patrick W. Serruys MD, PhD
doi : 10.1002/ccd.29490
Volume 98, Issue 7 p. 1287-1297
We aimed to update the logistic clinical SYNTAX score to predict 2 year all-cause mortality after contemporary percutaneous coronary intervention (PCI).
Predicting mortality after percutaneous coronary intervention: The need for improved risk models
Anirudh Kumar MD MSc,Hani Jneid MD
doi : 10.1002/ccd.29998
Volume 98, Issue 7 p. 1298-1299
Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly
James Cockburn MD,Tiffany Kemp MBBS,Peter Ludman MD,Tim Kinnaird MD,Tom Johnson MD,Nick Curzen PhD,Derek Robinson BSc,Mamas Mamas PhD,Adam de Belder MD,David Hildick-Smith MD,The British Cardiovascular Intervention Society (BCIS)
doi : 10.1002/ccd.29406
Volume 98, Issue 7 p. 1300-1307
Octogenarians are a high-risk group presenting for percutaneous coronary intervention (PCI). We aimed to create a 30-day mortality risk model for octogenarians presenting with both acute coronary syndrome (ACS) and chronic stable angina (CSA), using comprehensive mandatory UK data submissions to the UK National database.
You are only as old as you feel? It may depend on your score
Samuel M. Butman MD, FSCAI
doi : 10.1002/ccd.29992
Volume 98, Issue 7 p. 1308-1308
Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor
Monica Verdoia MD,Roberta Rolla MD,Patrizia Pergolini MD,Rocco Gioscia MD,Matteo Nardin MD,Federica Negro MD,Filippo Viglione MD,Harry Suryapranata MD, PhD,Elvin Kedhi MD,Giuseppe De Luca MD, PhD,Novara Atherosclerosis Study Group (NAS)
doi : 10.1002/ccd.29512
Volume 98, Issue 7 p. 1309-1316
Reduced levels of hemoglobin (Hb) represent an established marker of impaired outcomes and increased cardiovascular risk in patients with coronary artery disease, challenging the management of dual antiplatelet therapy (DAPT). However, while anemia has emerged as an independent predictor of suboptimal platelet inhibition in patients receiving clopidogrel, no study has so far evaluated the impact of Hb levels on high-on treatment platelet reactivity (HRPR) with ticagrelor and their prognostic consequences, that were the aim of the present study.
Utilization and outcomes of transcatheter coil embolization for various coronary artery lesions: Single-center 12-year experience
Omar M. Abdelfattah MD,Anas M. Saad MD,Nicholas Kassis MD,Shashank Shekhar MD,Toshiaki Isogai MD, MPH,Mohamed M. Gad MD,Keerat R. Ahuja MD,Essa Hariri MD,Manpreet Kaur MD,Medhat Farwati MD,Jaikirshan Khatri MD,Amar Krishnaswamy MD,Samir R. Kapadia MD
doi : 10.1002/ccd.29381
Volume 98, Issue 7 p. 1317-1331
Determining the outcomes of transcatheter coil embolization (TCE) for several coronary artery lesions.
When and how to close vessels in the cardiac catheterization laboratory
Spyridon Kostantinis MD,Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.29990
Volume 98, Issue 7 p. 1332-1334
Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study
Atul Abhyankar MD, DM,Alexandre Abizaid MD, PhD,Daniel Chamié MD, PhD,Gaurang Patel MD
doi : 10.1002/ccd.29371
Volume 98, Issue 7 p. 1335-1342
The aim of SiBi study was to evaluate the early vascular healing and neointimal coverage after implantation of ultrathin (60??m) biodegradable polymer-coated Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) sirolimus-eluting stent (SES) using optical coherence tomography (OCT) at 4 to 6?weeks after implantation.
Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia
Tao Yin MD,Xin Zhong MD,Ling Tao MD,Tao Hu MD
doi : 10.1002/ccd.29931
Volume 98, Issue 7 p. 1343-1348
Left main coronary artery atresia (LMCAA) is a rare congenital anomaly of the coronary artery that may have an unfavorable prognosis if left untreated. Surgical revascularization by either coronary artery bypass grafting or coronary reconstruction osteoplasty is unanimously recognized as the treatment of choice for this condition. Here, we first report a case of LMCAA treated with revascularization by percutaneous coronary intervention (PCI) through a retrograde approach. Intravascular ultrasound revealed an unusual coronary structure for the left main artery. PCI appears to be a feasible and effective alternative to surgery for the treatment of LMCAA, particularly if a minimally invasive method is desired.
The appropriate use criteria: Improvements for its integration into real world clinical practice
Lloyd W Klein MD,Jacqueline Tamis-Holland MD,Ajay J Kirtane MD, SM,H Vernon Anderson MD,Joaquin Cigarroa MD,Peter L Duffy MD,James Blankenship MD, MACC,C. Michael Valentine MD, MACC,Frederick GP Welt MD,For The AUC Workgroup of the ISLC Endorsed by the Interventional Section Leadership Council, American College of Cardiology
doi : 10.1002/ccd.29784
Volume 98, Issue 7 p. 1349-1357
The purpose of this position statement is to suggest ways in which future appropriate use criteria (AUC) for coronary revascularization might be restructured to: (1) incorporate improvement in quality of life and angina relief as primary goals of therapy, (2) integrate the findings of recent trials into quality appraisal, (3) employ the combined information of the coronary angiogram and invasive physiologic measurements together with the results of stress test imaging to assess risk, and (4) recognize the essential role that patient preference plays in making individualized therapeutic decisions. The AUC is a valuable tool within the quality assurance process; it is vital that interventionists ensure that percutaneous coronary intervention case selection is both evidence-based and patient oriented. Appropriate patient selection is an important quality indicator and adherence to evidence-based practice should be one metric in a portfolio of process and outcome indicators that measure quality.
Restriction of congenital portosystemic shunt using the modified microvascular plug
Sruti Rao MD,Karunakaravel Karuppasamy MD,Kadakkal Radhakrishnan MD,Thomas E. Fagan MD
doi : 10.1002/ccd.29934
Volume 98, Issue 7 p. 1358-1362
Congenital portosystemic shunts (CPSS) may produce a variety of severe, clinically detrimental presentations. When indicated, closure is recommended; however, if the intrahepatic portal venous system (IPVS) is underdeveloped complete closure may not be possible and may result in severe acute portal hypertension. Staged restriction of CPSS flow by both surgical and complex transcatheter interventions has been successful in augmenting development of the IPVS such that complete occlusion of the CPSS can be performed. We report use of a modified microvascular plug to restrict CPSS flow with subsequent IPVS development and safe complete occlusion of CPSS.
Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions Registry
Adam C. Salisbury MD, MSc,David M. Safley MD,Kevin F. Kennedy MS,Bhaskar Bhardwaj MD,Herbert D. Aronow MD, MPH,William Schuyler Jones MD,Dmitriy N. Feldman MD,Eric Secemsky MD, MSc,Thomas T. Tsai MD, Msc,Robert R. Attaran MBBS,John A. Spertus MD, MPH
doi : 10.1002/ccd.29961
Volume 98, Issue 7 p. 1363-1372
To develop a model to predict risk of in-hospital bleeding following endovascular peripheral vascular intervention.
Do we have an ideal bleeding prediction scoring system yet?
Mehmet Cilingiroglu MD,Ismail Dogu Kilic MD
doi : 10.1002/ccd.29987
Volume 98, Issue 7 p. 1373-1374
Finding the optimal access for proximal upper limb artery (PULA) interventions: Lessons learned from the PULA multicenter registry
Sándor Nardai MD, PhD,Biljana Zafirovska MD,Ákos Pataki MD,Balázs Nemes MD, PhD,Júlia Tóth MD,Mónika Deák MD,Sasko Kedev MD, PhD,Olivier Francois Bertrand MD, PHD,Charles Pirlet MD,Béla Merkely MD, PhD,Zoltán Ruzsa MD, PhD
doi : 10.1002/ccd.29967
Volume 98, Issue 7 p. 1375-1382
The multicenter proximal upper limb artery (PULA) Registry was created to study the optimal puncture sites for the interventions involving the subclavian, axillary, and innominate arteries.
Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach
Assi Milwidsky MD,Miguel Alvarez Villela MD,Jose Wiley MD MPH,Cristina Sanina MD,Snehal R. Patel MD,Nicole Sutton MD,Azeem Latib MD,Daniel B. Sims MD,Stephen J. Forest MD,Julia J. Shin MD,Muhammad U. Farooq MD,Daniel J. Goldstein MD,Ulrich P Jorde MD
doi : 10.1002/ccd.29785
Volume 98, Issue 7 p. 1383-1390
The use of the HeartMate 3 (HM3) left ventricular assist device (LVAD) is expanding. Despite being associated with lower rates of adverse events and increased survival, outflow graft obstruction (OGO) has been reported in patients with HM3. The incidence and best management of this serious complication remain unclear.
Outflow graft obstruction in patients with left ventricular assist devices: Stenting the kink
Alexander Postalian MD,Zvonimir Krajcer MD
doi : 10.1002/ccd.29994
Volume 98, Issue 7 p. 1391-1392
Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography
Dennis Rottländer MD,Miriel Gödde MD,Hubertus Degen MD,Alev Ögütcü MD,Martin Saal MD,Michael Haude MD
doi : 10.1002/ccd.29824
Volume 98, Issue 7 p. 1393-1401
Coronary sinus (CS) based mitral annuloplasty using the Carillon device could be limited by compromise of the left circumflex artery (Cx).
Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: “There is more to this than meets the eye!”
Issam D. Moussa MD, MBA
doi : 10.1002/ccd.29986
Volume 98, Issue 7 p. 1402-1403
Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair
Nicolas Brugger MD,Mohammad Kassar MD,George C. M. Siontis MD,Sonja Widmer MD,Taishi Okuno MD,Mirjam G. Winkel MD,Noé Corpataux MD,Christoph Gräni MD,Lutz Büllesfeld MD,Lukas Hunziker MD,Thomas Pilgrim MD,Stephan Windecker MD,Fabien Praz MD
doi : 10.1002/ccd.29916
Volume 98, Issue 7 p. 1404-1412
To investigate whether the integrative echocardiographic criteria used in the cardiovascular outcomes assessment of the mitraclip percutaneous therapy (COAPT) for heart failure patients with functional mitral regurgitation study predict outcomes after edge-to-edge trancatheter mitral valve repair (TMVr) for the treatment of secondary mitral regurgitation (SMR).
Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
Francesco Saia MD, PhD
doi : 10.1002/ccd.29989
Volume 98, Issue 7 p. 1413-1414
The CathPCI Registry (still) welcomes ambulatory surgical center participation
Kendrick A. Shunk MD, PhD, FSCAI
doi : 10.1002/ccd.29947
Volume 98, Issue 7 p. 1415-1415
Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique
Hady Lichaa MD, FSCAI, FSVM, RPVI
doi : 10.1002/ccd.29940
Volume 98, Issue 7 p. E977-E984
In patients with renal insufficiency, advanced techniques have been described to achieve ultra-low contrast or zero contrast percutaneous coronary interventions (PCI). However, these techniques use intra-coronary imaging before stent placement to determine adequate landing zones, by correlating them with saved fluoroscopic landmarks. Still, this leaves the operator with a certain degree of uncertainty about the exact lesion coverage, which is checked with post-stent intra-coronary imaging. We hereby describe a novel technique which takes away the concern of uncertainty regarding stent-landing zones and allows for the highest amount of precision in stent positioning, arguably even better than with the use of angiography. This technique involves positioning coronary stents under the live guidance of an intravascular ultrasound (IVUS) catheter which is positioned simultaneously, side by side to a stent. This technique takes advantage of all the benefits of IVUS based PCI without losing the precision in stent positioning when compared to traditional angiography. It simplifies the application of low contrast PCI by the interventional cardiology community, while maintaining the confidence in precise stenting. It has also the potential to decrease the incidence of contrast-induced nephropathy, hence procedural morbidity, while allowing for optimal long-term image based PCI outcomes. Obviously, it applies to moderate or larger coronary segments, without significant tortuosity. It also comes at the expense of slightly larger guide catheters, which is compensated for by the use of thin walled sheaths or sheathless catheter systems. Finally, radial access is still applicable depending on radial artery size and available equipment.
Percutaneous closure of a post-surgical ascending aortic pseudoaneurysm with an amplatzer septal occluder device and steerable guiding sheath
Graham R. McClure MD, MSc,Geemitha Ratnayake BSc,Albert Chan MD, MSc,Joel Gagnon MD
doi : 10.1002/ccd.29951
Volume 98, Issue 7 p. E985-E989
Thoracic pseudoaneurysm in the ascending aorta is an uncommon condition associated with significant risk of morbidity and mortality. Treatment is recommended in all cases regardless of symptoms as the mortality rate if left untreated has been documented to be as high as 61%. The current standard of care for managing these lesions is open surgical repair. However, this is associated with significant morbidity. In-hospital mortality reported for patients undergoing surgical repair of an ascending aortic pseudoaneurysm ranges from 6.7% to 41%. When anatomically suitable, a less invasive approach using amplatzer vascular plug or septal occluder is an attractive approach. We present a case report of repair of a post-surgical ascending aortic false aneurysm using an amplatzer septal occluder with an Oscor ™ steerable guiding sheath; a novel approach to increase platform stability when engaging an aneurysm neck. Endovascular occluder deployment for closure of aortic false aneurysms remains a relatively novel technique. It is limited by the requirement to develop a stable endovascular platform to deliver the device and avoid system prolapse, particularly when accessing challenging lesions on the inner aortic curvature. We present the first case to utilize a steerable guiding sheath system to improve system stability and facilitate successful device delivery. Given the significant morbidity associated with open repair of these lesions we hope this will further expand the range of lesions viewed as appropriate for endovascular repair.
Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation–A retrospective cohort study
Sa'ar Minha MD,Yuval Yarkoni BMSc,Amit Segev MD,Ariel Finkelstein MD,Haim Danenberg MD,Paul Fefer MD,Katia Orvin MD,Arie Steinvil MD,Elad Maor MD, PHD,Roy Beinart MD,Raphael Rosso MD,Gregory Golovchiner MD,Ran Kornowski MD,Victor Guetta MD,Israel M. Barbash MD
doi : 10.1002/ccd.29891
Volume 98, Issue 7 p. E990-E999
This study aimed to compare permanent pacemaker implantation (PPMI) rates among patients undergoing Trans-catheter Aortic Valve Implantation (TAVI) with first generation (G1) versus second generation (G2) valves and the impact of PPMI on long-term mortality.
Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip
Leonhard Moritz Schneider MD,Nita Nicoleta MD,Niklas Schepperle MD,Michael Paukovitsch MD,Uli Haide MD,Sieglinde Feuerabendt MD,Mirjam Keßler MD,Wolfgang Rottbauer MD,Sinisa Markovic MD
doi : 10.1002/ccd.29893
Volume 98, Issue 7 p. E1000-E1006
We investigated the impact of underlying pulmonary limitations (PL) on symptoms and clinical outcomes after transcatheter mitral valve repair (TMVr).
Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valve replacement: A meta-analysis
Spencer C. Lacy MD, MPH,Garly R. Saint Croix MD,Kadijah Porter MD,Azeem Latib MD,Nirat Beohar MD
doi : 10.1002/ccd.29911
Volume 98, Issue 7 p. E1007-E1016
This systematic review and meta-analysis compares direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation and bioprosthetic valve replacement or repair (BVR).
Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement
Motoki Fukutomi MD,Thijmen Hokken MD,Ivan Wong MD,Gintautas Bieliauskas MD,Joost Daemen MD, PhD,Peter de Jaegere MD, PhD,Nicolas Van Mieghem MD, PhD,Lars Søndergaard MD, DMSc,Ole De Backer MD, PhD
doi : 10.1002/ccd.29914
Volume 98, Issue 7 p. E1017-E1025
To report on the experience with a selective prophylactic permanent pacemaker (PPx-PPM) implantation strategy in patients with pre-existing right bundle branch block (RBBB) undergoing transcatheter aortic valve replacement (TAVR).
30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis
Birendra Amgai MBBS,Neelkumar Patel MD,Sandipan Chakraborty MD, MBBS,Dhrubajyoti Bandyopadhyay MBBS, MD,Adrija Hajra MBBS, MD, MRCP (UK),Soniya Koirala MD,Raktim K. Ghosh MBBS, MD, FACP,Wilbert S. Aronow MD,Carl J. Lavie MD,Gregg C. Fonarow MD,J. Dawn Abbott MD,Samir Kapadia MD
doi : 10.1002/ccd.29918
Volume 98, Issue 7 p. E1026-E1032
Transcatheter aortic valve replacement (TAVR) is being increasingly used for decompensated severe symptomatic aortic stenosis. Data on urgent and elective TAVR readmission is scarce in the literature. Here, we have performed a retrospective cohort study with the Nationwide Readmission Database of 2016 to identify the rate of 30-day all-cause readmission, common causes of readmission, and distribution of morbidity in index admission and readmission after urgent and elective TAVR.
Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis
Catarina Brízido MD,Márcio Madeira MD,João Brito MD,Sérgio Madeira MD,Rui Campante Teles MD,Luís Raposo MD,Henrique Mesquita Gabriel MD,Tiago Nolasco MD,Pedro de Araújo Gonçalves MD, PhD,Miguel Sousa-Uva MD, PhD,Miguel Abecasis MD,Manuel de Sousa Almeida MD, PhD,José Pedro Neves MD,Miguel Mendes MD
doi : 10.1002/ccd.29948
Volume 98, Issue 7 p. E1033-E1043
Recent studies suggest the use of transcatheter aortic valve implantation (TAVI) as an alternative to surgical aortic valve replacement (SAVR) in lower risk populations, but real-world data are scarce.
The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011–2017 US hospital database
David Uihwan Lee MD,John Han MS,Gregory Hongyuan Fan BA,David Jeffrey Hastie BA,Jean Kwon BS,Ki Jung Lee BS,Elyse Ann Addonizio BA,Raffi Karagozian MD
doi : 10.1002/ccd.29952
Volume 98, Issue 7 p. E1044-E1057
In this study, we use a national database to evaluate post-transcatheter (TAVR)/surgical aortic valve replacement (SAVR) outcomes stratified using chronic liver disease (CLD).
Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry
Shingo Matsumoto MD,Yohei Ohno MD,Junichi Miyamoto MD,Yuji Ikari MD,Norio Tada MD,Toru Naganuma MD,Masahiro Yamawaki MD,Futoshi Yamanaka MD,Shinichi Shirai MD,Kazuki Mizutani MD,Minoru Tabata MD,Hiroshi Ueno MD,Kensuke Takagi MD,Yusuke Watanabe MD,Masanori Yamamoto MD,Kentaro Hayashida MD,The OCEAN-TAVI Investigators
doi : 10.1002/ccd.29960
Volume 98, Issue 7 p. E1058-E1065
To identify the vulnerable diabetic cohort in patients undergoing transcatheter aortic valve replacement (TAVR).
